Damora Therapeutics Inc

Damora Therapeutics insider option grants reveal a strategic move to align leadership with future share‑price growth, spotlighting FDA milestones, capital‑raising plans, and market risks that investors must watch closely.

Damora Therapeutics’ insider stock‑option grants signal executive confidence and align leadership with long‑term shareholder value, hinting at future upside amid a growing pipeline.